A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma
Derek Shek, Jeff Longmate, David I. Quinn, Kim A. Margolin, Przemyslaw Twardowski, David R. Gandara, Paul Frankel, Chong-Xian Pan, Primo N. LaraVolume:
16
Language:
english
Pages:
6
DOI:
10.1007/s10147-011-0212-8
Date:
October, 2011
File:
PDF, 1.60 MB
english, 2011